Data from University of Texas MD Anderson Cancer Center Provide New Insights into Antibodies (Preclinical Development of 1b7/cd3, a Novel Anti-tslpr Bispecific Antibody That Targets Crlf2-rearranged Ph-like B-all).

Keywords: Houston; State:Texas; United States; North and Central America; Antibodies; Bispecific Antibodies; Blood Proteins; Immunoglobulins; Immunology; Immunoproteins; Proteins EN Houston State:Texas United States North and Central America Antibodies Bispecific Antibodies Blood Proteins Immunoglobulins Immunology Immunoproteins Proteins 1502 1502 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Immunology - Antibodies. Then we present and evaluate the anti-tumor characteristics of 1B7/CD3, a novel CD3-redirecting bispecific antibody (BsAb) that co-targets TSLPR. [Extracted from the article]